Cargando…

Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck

A subset of circulating T cells (CD8(+)CD45RO(−)CD27(−)) with a naïve phenotype, but mediating effector function, is considered to play an important role in host antitumour defence. To investigate the attributes of these effector T cells in patients with squamous cell carcinoma (SCC) of the head and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuss, I, Donnenberg, A D, Gooding, W, Whiteside, T L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377049/
https://www.ncbi.nlm.nih.gov/pubmed/12610507
http://dx.doi.org/10.1038/sj.bjc.6600694
_version_ 1782154766539816960
author Kuss, I
Donnenberg, A D
Gooding, W
Whiteside, T L
author_facet Kuss, I
Donnenberg, A D
Gooding, W
Whiteside, T L
author_sort Kuss, I
collection PubMed
description A subset of circulating T cells (CD8(+)CD45RO(−)CD27(−)) with a naïve phenotype, but mediating effector function, is considered to play an important role in host antitumour defence. To investigate the attributes of these effector T cells in patients with squamous cell carcinoma (SCC) of the head and neck cancer, venous blood was obtained from 39 individuals with cancer and 45 normal controls (NC). Peripheral blood mononuclear cells were isolated, stained with labelled monoclonal antibodies specific for CD8, CD45RO, CD45RA, CD62L, CD27, TCR-ζ as well as isotype controls and examined by multicolour flow cytometry. Annexin V binding to CD8(+) T cells and PMA/ionomycin-induced IFN-γ expression were also evaluated in patients and NC. The proportions of CD45RA(+)CD45RO(−) (naïve) and CD45RA(−)CD45RO(+) (memory) cells were found to be comparable within the CD8(+) T-cell subset. However, relative to NC, the frequency of effector CD8(+)CD45RO(−)CD27(−) cells was strikingly increased in all SCC patients regardless of the disease status (P=0.0003). The proportion of these cells was found to increase with age in both patients and NC. In NC, stimulated IFN-γ expression was largely restricted to CD8(+)CD45RO(−)CD27(+) cells, while in patients CD8(+)CD45RO(−)CD27(−) expressed IFN-γ after ex vivo stimulation. Expression of the TCR-associated ζ chain was decreased or absent in freshly isolated CD8(+)CD45RO(−)CD27(−) T cells in patients (P<0.0001). Annexin V was found to bind to a higher proportion of circulating CD8(+) T cells in patients than NC (P<0.006), and significantly more Annexin V(+) T cells were present in the effector (P<0.0059) than the naïve subset within the CD8(+)CD45RO(−) compartment. The data indicate that the expanded CD8(+)CD45RO(−)CD27(−) T cells, which contain precursors of IFN-γ-producing T cells, are ζ-negative and sensitive to apoptosis in the circulation of patients with HNC.
format Text
id pubmed-2377049
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23770492009-09-10 Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck Kuss, I Donnenberg, A D Gooding, W Whiteside, T L Br J Cancer Molecular and Cellular Pathology A subset of circulating T cells (CD8(+)CD45RO(−)CD27(−)) with a naïve phenotype, but mediating effector function, is considered to play an important role in host antitumour defence. To investigate the attributes of these effector T cells in patients with squamous cell carcinoma (SCC) of the head and neck cancer, venous blood was obtained from 39 individuals with cancer and 45 normal controls (NC). Peripheral blood mononuclear cells were isolated, stained with labelled monoclonal antibodies specific for CD8, CD45RO, CD45RA, CD62L, CD27, TCR-ζ as well as isotype controls and examined by multicolour flow cytometry. Annexin V binding to CD8(+) T cells and PMA/ionomycin-induced IFN-γ expression were also evaluated in patients and NC. The proportions of CD45RA(+)CD45RO(−) (naïve) and CD45RA(−)CD45RO(+) (memory) cells were found to be comparable within the CD8(+) T-cell subset. However, relative to NC, the frequency of effector CD8(+)CD45RO(−)CD27(−) cells was strikingly increased in all SCC patients regardless of the disease status (P=0.0003). The proportion of these cells was found to increase with age in both patients and NC. In NC, stimulated IFN-γ expression was largely restricted to CD8(+)CD45RO(−)CD27(+) cells, while in patients CD8(+)CD45RO(−)CD27(−) expressed IFN-γ after ex vivo stimulation. Expression of the TCR-associated ζ chain was decreased or absent in freshly isolated CD8(+)CD45RO(−)CD27(−) T cells in patients (P<0.0001). Annexin V was found to bind to a higher proportion of circulating CD8(+) T cells in patients than NC (P<0.006), and significantly more Annexin V(+) T cells were present in the effector (P<0.0059) than the naïve subset within the CD8(+)CD45RO(−) compartment. The data indicate that the expanded CD8(+)CD45RO(−)CD27(−) T cells, which contain precursors of IFN-γ-producing T cells, are ζ-negative and sensitive to apoptosis in the circulation of patients with HNC. Nature Publishing Group 2003-01-27 2003-01-28 /pmc/articles/PMC2377049/ /pubmed/12610507 http://dx.doi.org/10.1038/sj.bjc.6600694 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular and Cellular Pathology
Kuss, I
Donnenberg, A D
Gooding, W
Whiteside, T L
Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
title Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
title_full Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
title_fullStr Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
title_full_unstemmed Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
title_short Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
title_sort effector cd8(+)cd45ro(−)cd27(−)t cells have signalling defects in patients with squamous cell carcinoma of the head and neck
topic Molecular and Cellular Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377049/
https://www.ncbi.nlm.nih.gov/pubmed/12610507
http://dx.doi.org/10.1038/sj.bjc.6600694
work_keys_str_mv AT kussi effectorcd8cd45rocd27tcellshavesignallingdefectsinpatientswithsquamouscellcarcinomaoftheheadandneck
AT donnenbergad effectorcd8cd45rocd27tcellshavesignallingdefectsinpatientswithsquamouscellcarcinomaoftheheadandneck
AT goodingw effectorcd8cd45rocd27tcellshavesignallingdefectsinpatientswithsquamouscellcarcinomaoftheheadandneck
AT whitesidetl effectorcd8cd45rocd27tcellshavesignallingdefectsinpatientswithsquamouscellcarcinomaoftheheadandneck